Interestingly, in very recent studies, CDH3 (also known as Cadherin-3 or Placental-Cadherin), have been shown to be served as an accurate survival predictor in lung cancer [69] and poor prognosis biomarker among patients with tongue squamous cell carcinoma [70], indicating its importance in other cancers. The gene discussed is CDH3; the disease is tongue squamous cell carcinoma.